
Aurora Cannabis urges shareholders to wait for board review before acting on Curaleaf's revised hostile takeover bid.
Aurora Cannabis announced that its Special Committee will conduct a thorough review of Curaleaf's revised hostile takeover bid offering US$5.00 per share. Shareholders are advised to take no action until the Board provides a formal recommendation, ex...




